[P] Poster (5. Vaccine)

[P099] Serotype-Specific Neutralization and Antibody-Dependent Enhancement in a Dengue Community Cluster Cohort in Bandung, Indonesia (2005–2009)

○Malihe Naderi¹, Chrisan Bimo Prayuda^2,3, Jean Claude Balingit^1,4, Silvita Fitri Riswari^2,5, Gita Widya Pradini^2,5, Siti Rasnawati Mony², Dionisius Denis⁶, Diana S. Hansen⁷, Tedjo Sasmono⁸, Mya Myat Ngwe Tun^1,9,10,11, Kouichi Morita^1,9, Bachti Alisjahbana^2,5,12 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine (Japan), 2. Research Center for Care and Control of Infectious Disease (RC3ID), Universitas Padjadjaran, Indonesia (Indonesia), 3. Faculty of Medicine, Universitas Islam Bandung, Indonesia. (Indonesia), 4. Department of Clinical Microbiology, Umeå universitet, Sweden (Sweden), 5. Faculty of Medicine, Universitas Padjadjaran, Indonesia. (Indonesia), 6. Exeins Health Initiative (EHI), Jakarta, Indonesia (Indonesia), 7. Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, Australia (Australia), 8. Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Indonesia (Indonesia), 9. Department of Virology, Institute of Tropical Medicine, Nagasaki University. (Japan), 10. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 11. DEJIMA Infectious Disease Research Alliance, Nagasaki University (Japan), 12. Department of Internal Medicine, Hasan Sadikin General Hospital, Indonesia. (Indonesia))

閲覧にはパスワードが必要です